Assignee
WATSON PHARMACEUTICALS INC
US·21 granted patents·7 pending applications·978 citations·filing 1998–2014
Top patents by PatentIndex Score
28 records- 0197US6365178B1Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersionsWATSON PHARMACEUTICALS INC·Filed 2001·Granted Apr 2, 2002·112 cites·48 claims
- 0294US6583129B1Administration of non-oral androgenic steroids to womenWATSON PHARMACEUTICALS INC·Filed 2000·Granted Jun 24, 2003·99 cites·30 claims
- 0394US6210699B1Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavityWATSON PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·195 cites·47 claims
- 0493US6743441B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON PHARMACEUTICALS INC·Filed 2002·Granted Jun 1, 2004·42 cites·62 claims
- 0591US6866865B2Dosage forms and methods for oral delivery of progesteroneWATSON PHARMACEUTICALS INC·Filed 2003·Granted Mar 15, 2005·69 cites·8 claims
- 0691US6585963B1Nail compositions and methods of administering sameWATSON PHARMACEUTICALS INC·Filed 2001·Granted Jul 1, 2003·83 cites·22 claims
- 0786US7186706B2Administration of non-oral androgenic steroids to womenWATSON PHARMACEUTICALS INC·Filed 2002·Granted Mar 6, 2007·25 cites·18 claims
- 0886US6544553B1Dosage forms and methods for oral delivery of progesteroneWATSON PHARMACEUTICALS INC·Filed 1999·Granted Apr 8, 2003·91 cites·8 claims
- 0985US6730318B2Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive propertiesWATSON PHARMACEUTICALS INC·Filed 2001·Granted May 4, 2004·17 cites·15 claims
- 1084US7179483B2Compositions and methods for transdermal oxybutynin therapyWATSON PHARMACEUTICALS INC·Filed 2004·Granted Feb 20, 2007·11 cites·44 claims
- 1182US6180133B1Antioxidant composition for topical/transdermal prevention and treatment of wrinklesWATSON PHARMACEUTICALS INC·Filed 1998·Granted Jan 30, 2001·61 cites·22 claims
- 1279US7959946B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2004·Granted Jun 14, 2011·7 cites·18 claims
- 1379US6630166B1Compositions for conjugated estrogens and associated methodsWATSON PHARMACEUTICALS INC·Filed 2002·Granted Oct 7, 2003·15 cites·11 claims
- 1478US8668931B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2013·Granted Mar 11, 2014·1 cites·18 claims
- 1577USD439654STabletWATSON PHARMACEUTICALS INC·Filed 2000·Granted Mar 27, 2001·25 cites·1 claims
- 1675US7785627B2Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2003·Granted Aug 31, 2010·8 cites·5 claims
- 1773US6727401B1Pressure sensitive adhesive matrix patch for the treatment of onychomycosisWATSON PHARMACEUTICALS INC·Filed 1998·Granted Apr 27, 2004·41 cites·10 claims
- 1872US6153223AStabilized pharmaceutical compositionsWATSON PHARMACEUTICALS INC·Filed 1998·Granted Nov 28, 2000·47 cites·12 claims
- 1968US2015072001A1Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivativeWATSON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2064USD440650STabletWATSON PHARMACEUTICALS INC·Filed 2000·Granted Apr 17, 2001·15 cites·1 claims
- 2162US7338667B2Pharmaceutical formulationWATSON PHARMACEUTICALS INC·Filed 2003·Granted Mar 4, 2008·3 cites·9 claims
- 2258US2009004284A1Controlled release tamsulosin hydrochloride formulationWATSON PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2355US6693083B2Conjugates targeted to the interleukin-2 receptorWATSON PHARMACEUTICALS INC·Filed 2001·Granted Feb 17, 2004·11 cites·20 claims
- 2454US2004197397A1Drug delivery system for treatment of urinary incontinenceWATSON PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2553US2005100608A1Testosterone oral dosage formulations and associated methodsWATSON PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2651US2003124177A1Compositions and methods for transdermal oxybutynin therapyWATSON PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2750US2004202704A1Transdermal delivery systems and methodsWATSON PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2837US2004037873A1Norethindrone sustained release formulations and methods associated therewithWATSON PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →